text:
Choose your preferred language
Español Spanish (Mexico) English English
COVID-19 Vaccine Information, Resources and Frequently Asked Questions
Note: Information about the COVID-19 vaccine is changing rapidly. As we learn more, we will update the following Frequently Asked Questions with new information.
Memorial Hermann invites all members of the community to register for the COVID-19 vaccine at a Memorial Hermann vaccination clinic. Register Now »
Now Offering Walk-In COVID-19 Vaccine Clinics: Memorial Hermann is pleased to offer free COVID-19 vaccination walk-in clinics to community members across Greater Houston. Learn more »
Vaccines Administered*
Patients Vaccinated*
Patients Vaccinated with Both Doses*
*By Memorial Hermann Health System as of end of day 1/17/2022
About COVID-19 Vaccines About COVID-19 Booster Shots Getting Vaccinated At Memorial Hermann
COVID-19 Vaccine Guidance
As hospitals and doctor's offices work diligently to vaccinate our community as quickly as possible, we encourage everyone to:
Check the website. Memorial Hermann's website is the best source of accurate, up-to-date information related to our COVID-19 vaccine distribution process. By limiting calls and unscheduled visits to our hospitals and doctor's offices that are related to vaccine inquiries, we can more effectively assist and provide care for our patients and their loved ones.
Register for Vaccination. Memorial Hermann invites all eligible members of the community to register for the opportunity to receive the COVID-19 vaccine at a Memorial Hermann vaccination clinic.
Registered individuals will be notified when appointments are available. Memorial Hermann will make appointments available based on vaccine supply and will prioritize vaccine distribution in accordance with guidance from the Texas Department of State Health Services. Register Now »
About Vaccines
How do vaccines work?
Vaccines train the body's immune system to recognize and fight viruses and bacteria. When the body is exposed again to a virus after being vaccinated against it, the body is immediately ready to fight the illness. Vaccines currently save millions of lives every year by preventing diseases like diphtheria, tetanus, pertussis, measles and influenza.
How does a vaccine get FDA approved?
Getting a vaccine approved by the Food and Drug Administration (FDA) is a rigorous one, to ensure both safety and efficacy. The FDA must determine, based on substantial evidence and clinical data, that the vaccine is effective for immunizing people against the SARS-COV-2 virus and that its benefits outweigh its risks when used as intended. As of Aug. 23, 2021, the FDA has approved the Pfizer vaccine for distribution to individuals aged 16 years and older. Read more about the FDA's approval process.
The Moderna and Johnson & Johnson/Janssen COVID-19 vaccines have Emergency Use Authorization (EUA) from the FDA. What does that mean?
During a public health emergency, the FDA can issue an EUA to allow the use of unapproved medical products (or unapproved uses of approved medical products) to diagnose, treat or prevent serious or life-threatening diseases. Certain safety, efficacy and other criteria must be met using the best available evidence.
How do vaccines and herd immunity work together?
A virus can spread very quickly throughout a community infecting many people. However, if enough people get vaccinated, germs cannot spread from person to person as quickly and the vast majority of people will not get sick. This is what is known as herd immunity. Herd immunity protects everyone, especially those people who cannot receive a vaccine for one reason or another, those who do not have a strong immune response to vaccines, and those with serious allergies or weakened immune systems.
About COVID-19 Vaccines
Which COVID-19 vaccines are available now?
The vaccine developed by Pfizer has been approved by the FDA for people ages 16 years and older, and is available for children ages 5 to 15 under Emergency Use Authorization (EUA) by the FDA. Vaccines developed by Moderna and Johnson & Johnson have been granted EUA by the FDA for people ages 18 and older.
How many potential vaccines will there be for COVID-19?
Although three vaccines are available in the United States at this time, more are in development. To learn about ongoing trials and new developments, visit the Coronavirus Prevention Network website. The network was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health.
Several companies are developing COVID-19 vaccines. Are they all considered equal, or is one better than the others?
Each vaccine will undergo the same stringent FDA review process before it receives full approval or Emergency Use Authorization (EUA). As of now, the Pfizer vaccine has been fully approved, which means the FDA has determined, based on substantial evidence and clinical data, that the Pfizer vaccine is effective for immunizing people ages 16 and older against the SARS-CoV-2 virus and that its benefits outweigh its risks when used as intended. The Moderna and Johnson & Johnson vaccines have received EUA, which means the FDA has determined that, based on the best available evidence, the vaccines are safe and effective in preventing a COVID-19 infection. The Pfizer vaccine is available for children ages 5 to 15 under a EUA.
Notably, in Dec. 2021, the CDC issued a preferential recommendation for the use of the mRNA COVID-19 vaccines currently available in the U.S. (Pfizer and Moderna) over the Johnson & Johnson vaccine, citing rare but serious side effects.
How was the COVID-19 vaccine developed so quickly? Did this compromise the safety or effectiveness of the vaccine?
Before any vaccine is widely distributed to the public, it is tested in clinical trials on tens of thousands of people to determine its safety and efficacy. While development and authorization of the COVID-19 vaccines were accelerated through global collaboration and the urgency to end the pandemic, this does not mean that safety corners were cut; the vaccines went through the same stringent testing process that other vaccines go through before public dissemination.
How do we know the COVID-19 vaccine is safe and effective?
As of Aug. 23, 2021, the FDA – which is globally respected for its scientific standards of vaccine safety, effectiveness and quality – has fully approved the Pfizer vaccine for use in preventing COVID-19 in people ages 16 and older. This means the FDA has determined, based on substantial evidence and clinical data, that the Pfizer vaccine is effective for immunizing people against the SARS-CoV-2 virus and that its benefits outweigh its risks when used as intended.
In addition, the Moderna and Johnson & Johnson vaccines have undergone stringent review processes and received Emergency Use Authorization (EUA) from the FDA. This means the FDA has determined, based on the best available evidence, that the vaccines are safe and effective in preventing a COVID-19 infection. Prior to receiving FDA approval, the Pfizer vaccine was also distributed under an Emergency Use Authorization – and continues to be administered under a EUA to children ages 5 to 15.
The scientific and medical community is committed to continuing to evaluate all available evidence to improve understanding of these vaccines' safety. After clinical data revealed a very rare but serious side effect experienced by some individuals after receiving the Johnson & Johnson vaccine, the CDC issued a preferential recommendation for the use of the mRNA COVID-19 vaccines (Pfizer and Moderna) over the Johnson & Johnson vaccine in Dec. 2021.
I heard that the COVID-19 vaccine won't prevent me from getting COVID-19. So why should I be vaccinated?
It is a common misconception that vaccines prevent someone from contracting the virus. Vaccines train the body's immune system to recognize and fight viruses and bacteria. When the body is exposed to a virus after being vaccinated against it, the body is immediately ready to fight the illness. Because the body is able to respond more quickly, you are less likely to experience symptoms of the illness, especially severe and life-threatening ones. Based on clinical trials and observations following the administration of more than hundreds of millions of doses, we know the COVID-19 vaccines are extremely effective in preventing severe illness, hospitalization and death from the virus – including new strains such as the delta variant.
After receiving the COVID-19 vaccine, how long will I be protected?
At this time, there is not enough data about the vaccines to know how long they will provide protection from COVID-19.
If I already had COVID-19, do I still need to get vaccinated?
Yes. While doctors do not yet know how long you will be protected after having COVID-19, they do know it is possible to contract the virus again. Getting vaccinated protects you from suffering severe illness, hospitalization and death from COVID-19. In addition, preliminary data show that natural antibodies from a previous COVID-19 infection do not provide as much protection as the vaccines do against more contagious and aggressive strains of the virus, including the delta variant.
Do I have to continue wearing a mask and practicing social distancing after I receive the COVID-19 vaccine?
Yes. We all need to continue the 3 W's – wearing a mask, watching your distance and washing your hands regularly – until we know how long the vaccine protects against the virus and we gain community control of COVID-19.
Can I get COVID-19 from the vaccine?
No. None of the vaccines currently available use a live version of the virus, so a person who receives any of these vaccines cannot contract COVID-19 from the vaccination.
If I receive the vaccine, what side effects can I expect?
Side effects may vary depending on which vaccine you receive, but common side effects include fatigue, headache, muscle and joint pain, swollen lymph nodes and pain at the injection site, which is generally the upper arm. Before you receive your vaccine, specific information about your vaccine's anticipated side effects will be provided to you.
According to the State, who is eligible for COVID-19 vaccination?
Individuals 18 years of age or older are eligible to receive the Pfizer, Moderna and Johnson & Johnson COVID-19 vaccines. Children 5 to 17 years of age are eligible to receive only the Pfizer vaccine.
Where can I learn more about the COVID-19 vaccines?
Additional information about the vaccines can be found in the FDA's fact sheets for the Pfizer vaccine, Moderna vaccine and Johnson & Johnson vaccine. You may find general information about the COVID-19 vaccine on the FDA's website.
What should I do if I've received the Johnson & Johnson vaccine and am worried about developing blood clots or Guillain-Barre Syndrome?
In Dec. 2021, the CDC issued a preferential recommendation of the mRNA COVID-19 vaccines currently available in the U.S. (Pfizer and Moderna) over the Johnson & Johnson vaccine, citing rare but serious side effects. The decision was based on additional data showing 54 cases of blood clotting, more specifically a condition known as thrombosis with thrombocytopenia syndrome, or TTS, after the Johnson & Johnson vaccine. This condition has also been documented after the AstraZeneca vaccine (not authorized in the U.S.), which, like Johnson & Johnson, uses a genetically modified cold virus (instead of mRNA) to carry instructions for making the spike protein mimicking the one on the SARS-CoV-2 virus.
Of those 54 cases, 9 people died. Notably, more than 14 million doses of the Johnson & Johnson vaccine have been given in the U.S. as of Aug. 31, 2021, so this remains a very rare side effect, occurring at a reported rate of 3.83 per 1 million doses (with the death rate of .57 per 1 million doses). Rates of TTS were highest among females ages 30 to 39. (Data from December 2021)
While the chance of developing blood clots, Guillain-Barre Syndrome or any other adverse reaction from the Johnson & Johnson COVID-19 vaccine is extremely rare, individuals should contact their healthcare provider if they develop serious symptoms in the days and weeks after being vaccinated. Symptoms of blood clots may include headache, blurred vision, fainting or loss of consciousness, loss of control over movement in part of the body, abdominal pain, shortness of breath, leg pain/swelling and seizures. Symptoms of Guillain-Barre Syndrome may include varying degrees of weakness or tingling sensations starting in the legs and hands, loss of reflexes and an inability to walk, climb stairs or maintain steadiness when walking.
What symptoms should I look out for if I receive the Johnson & Johnson vaccine?
Can I still get the Johnson & Johnson vaccine in light of the CDC's preferential recommendation for the mRNA vaccines (Pfizer and Moderna)?
Yes. The preferential recommendation still allows individuals to receive the Johnson & Johnson vaccine, including if they are unable to or uncomfortable getting an mRNA vaccine. Following this guidance from the CDC, Memorial Hermann recommends the Pfizer and Moderna COVID-19 vaccines over the Johnson & Johnson vaccine for those who meet vaccine eligibility. Moving forward, we will follow the below guidelines from the CDC:
Education about the risk for adverse events after the Johnson & Johnson COVID-19 vaccine is required to guide vaccine decision-making.
The Johnson & Johnson COVID-19 vaccines may be offered to the following populations: individuals who received the Johnson & Johnson primary dose and seek it as their booster dose; individuals with a contraindication to mRNA COVID-19 vaccines (e.g. severe allergic reaction after a previous dose or to a component of an mRNA COVID-19 vaccine); individuals who would otherwise remain unvaccinated for COVID-19 due to limited access to mRNA COVID-19 vaccines; and individuals who would prefer the Johnson & Johnson COVID-19 vaccine despite safety concerns identified.
Will the vaccine affect my DNA?
No. The COVID-19 vaccines do not affect DNA. The vaccines train the body's immune system to recognize and fight the virus.
Do I have to show proof of residency?
No. You do not have to show proof of residency to get a COVID-19 vaccine, and you do not need a Social Security number.
Do I have to show my ID when I get vaccinated?
Yes. To ensure we have accurate information for your vaccine record, we will ask for your photo ID. Any of the following forms of identification will be acceptable as photo ID:
Driver's licenses or other state photo identity cards issued by Department of Motor Vehicles (or equivalent). We will accept current or expired identifications.
U.S. or foreign government-issued passport or identifications
A credit card with a photo
Employment or Student Identification card with photo
Can I get the vaccine if I am pregnant or breastfeeding?
Yes. The Centers for Disease Control and Prevention (CDC) has recommended that pregnant women get a COVID-19 vaccine after research showed that the vaccine does not pose additional risks for mothers or babies. In addition, the CDC has stated the vaccines pose no risk for breastfeeding women or their babies. In fact, studies have shown that the COVID-19 vaccine provides protection to infants through breast milk.
If you are pregnant or breastfeeding, we encourage you to have a conversation with your healthcare provider to help you decide. In addition, according to the CDC, the mRNA vaccines currently available in the U.S. (Pfizer and Moderna) are recommended over the Johnson & Johnson vaccine, citing rare but serious side effects.
COVID-19 Vaccines and Children
How do we know that the COVID-19 vaccine is safe and effective for children?
The U.S. Food and Drug Administration (FDA), which authorized emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in children ages 5-11, is globally respected for its scientific standards of vaccine safety, effectiveness and quality. The FDA evaluated data from 3100 pediatric study participants to ensure that each vaccine is safe. Based on this research, the American Academy of Pediatrics recommends that anyone who is eligible to receive the COVID-19 vaccine get vaccinated as soon as possible.
In general, children have been at low risk from developing serious illness from COVID-19. Why should they get vaccinated?
Keep in mind, low risk is not no risk. While most children with COVID-19 have mild symptoms or have no symptoms at all, severe illness and death have been reported in children under the age of 1 as well as in children with underlying health conditions. Vaccines are helpful in preventing illness and disease, and the COVID-19 vaccine is no different. Getting vaccinated protects children from developing severe complications from COVID-19 and may reduce the chance they could spread the infection to other more vulnerable family members and friends. Clinical trials in children ages 5-11 years found the vaccine to be 90.7% effective in preventing symptomatic COVID-19.
My child has had COVID-19. Will my child's antibodies be enough to protect them from another infection?
While doctors do not know yet how long we are protected after having COVID-19, they do know it is possible to contract the virus again—and early research is showing that natural immunity may not be as effective as vaccines in protecting against new strains of the virus. The CDC recommends vaccination even for those who were previously infected, especially as more infectious COVID-19 variants develop.
If I have received my COVID-19 vaccine, will that be enough to protect my children from contracting the virus?
Although less likely, it is possible for vaccinated individuals to contract COVID-19 and spread it to others. This combined with more transmissible COVID-19 variants – which account for the majority of current cases in the U.S. – puts children at risk of getting sick with the virus and spreading it to others, particularly while in close contact with other children.
What side effects can my child expect after receiving the COVID-19 vaccine?
As with other vaccines, children may feel tired or have a sore arm, low-grade fever and other flu-like symptoms following COVID-19 vaccination. However, these symptoms are typically mild and go away within 48 hours.
Does the COVID-19 vaccine have a long-term impact on fertility? How can I be sure it won't affect my child's development?
According to the Centers for Disease Control and Prevention (CDC), there is no evidence that any vaccine, including the COVID-19 vaccine, impacts development or fertility.
If my child has food allergies, is it safe for them to get the COVID-19 vaccine?
Yes. Children with food allergies can safely get the COVID-19 vaccine. Unlike the flu shot, the COVID-19 vaccine does not contain food products such as egg proteins. If your child is allergic to polyethylene glycol (PEG), or has experienced a severe allergic reaction to other injectable treatments, please consult with a doctor.
There have been reports of heart inflammation in young people after receiving the COVID-19 vaccine. How should this impact my decision whether to vaccinate my child?
Federal health officials—including those with the American Academy of Pediatrics—have advised that heart inflammation (myocarditis and pericarditis) is an extremely rare side effect of the COVID-19 vaccine. Importantly, for the young people who do experience this side effect, most cases are mild and individuals recover often on their own or with minimal treatment. Myocarditis and pericarditis are much more common in individuals who contract COVID-19, and the risks to the heart from COVID-19 infection can be more severe.
Can the COVID-19 vaccine be administered with other vaccines, such as the flu shot, at the same time?
Yes, according to the CDC, the COVID-19 vaccine may be given simultaneously with other vaccines. Extensive experience with non-COVID-19 vaccines has shown that the ability of a vaccine to create an immune response and potential side effects are generally similar when vaccines are administered simultaneously as when they are administered alone.
How many doses of the COVID-19 vaccine does my child need and when should they get them?
The FDA has authorized a two-dose series of the Pfizer COVID-19 vaccine for children 5 to 17 years of age, with a recommended booster shot five months later for individuals 12 and older.
For individuals ages 5 and older who are moderately or severely immunocompromised, the CDC recommends an additional primary dose of vaccine 28 days after the second shot.
What is the difference between the COVID-19 vaccine for children under 12 and the vaccine authorized for children and adults age 12 and older?
The COVID-19 vaccine dose for children ages 5 to 11 is one-third of the dose authorized for children ages 12 to 17. Other than the dose amount, there are no other differences between these vaccines, and both are highly effective.
Am I able to get my child vaccinated with Memorial Hermann?
Memorial Hermann is pleased to offer free COVID-19 vaccinations for children 5 years of age and older.
Anyone age 5 to 11 who wishes to receive the COVID-19 vaccine may visit any of Memorial Hermann's COVID-19 Vaccine Walk-In Clinics that offer the Pfizer vaccine. Note: Memorial Hermann locations administering the Moderna or Johnson & Johnson vaccine will only vaccinate individuals 18 years of age and older. To schedule an appointment at one of Memorial Hermann's COVID-19 Vaccine Clinics, please complete the online COVID-19 Vaccination Request Form. Appointments are not required. Minors (individuals ages 5 to 17) must be accompanied by an adult at the time of vaccination.
If you prefer to be vaccinated at a pediatrician's office, the COVID-19 vaccine will be offered to new (with doctor's visit) and established patients ages 5 and above, with an appointment at Children's Memorial Hermann Pediatrics locations and a number of Memorial Hermann-affiliated pediatrician practices. Parents should call the pediatrician's office to schedule their appointment. Appointments will be available Monday through Friday. Minors (individuals ages 5 to 17) must be accompanied by an adult at the time of vaccination.
COVID-19 Booster Shot
What is the difference between a COVID-19 vaccine booster shot and additional primary series/third dose?
A COVID-19 booster shot is intended to increase the level of protection for eligible individuals who received an initial Pfizer or Moderna vaccine series at least 5 months prior or a Johnson & Johnson vaccine at least 2 months prior.
A COVID-19 additional primary series dose, or third dose, is intended to improve the response of moderately to severely immunocompromised individuals to their initial Pfizer or Moderna vaccine series. An additional or third dose can be administered at least 4 weeks following the second dose of Pfizer or Moderna.
Who is eligible for a COVID-19 vaccine booster shot or additional primary series/third dose?
In line with guidance from the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), Memorial Hermann is offering COVID-19 vaccine booster shots to all eligible members of our community ages 12 and older.
Please pay careful attention to the eligibility guidelines below:
Individuals ages 12 to 17 who received a Pfizer COVID-19 vaccine primary series are eligible for a Pfizer booster shot at least five (5) months after their second dose.
Individuals 18 and older who received a Pfizer or Moderna COVID-19 vaccine are eligible for a Pfizer or Moderna booster shot at least five (5) months after their second dose.
For individuals who received a Johnson & Johnson COVID-19 vaccine, a booster shot is recommended if they received the single-dose vaccine at least two (2) months ago.
In most situations, the Pfizer or Moderna mRNA COVID-19 vaccines are preferred over the Johnson & Johnson COVID-19 vaccine for primary and booster vaccination.
For those who are moderately to severely immunocompromised, the CDC recommends an additional primary series dose – or a third dose – of the Pfizer or Moderna vaccine at least 28 days after the second dose is administered.
Individuals should speak with their physician to determine whether a booster shot or additional/third dose of the COVID-19 vaccine is recommended for them and, if so, which one.
What qualifies as a moderately to severely compromised immune system?
According to the CDC, individuals with moderately to severely compromised immune systems include those who have:
Been receiving active cancer treatment for tumors or cancers of the blood.
Received an organ transplant and are taking medicine to suppress the immune system.
Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system.
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome).
Advanced or untreated HIV infection.
Active treatment with high-dose corticosteroids or other drugs that may suppress their immune response.
Does my COVID-19 booster shot have to be the same type of vaccine as my initial vaccine series?
According to the CDC, individuals 18 and older may choose the type of vaccine they receive as a booster, and it does not matter which vaccine they received for their initial series. Some may have a preference for the vaccine type that they originally received and others may prefer to get a different booster. In most situations, the Pfizer or Moderna mRNA COVID-19 vaccines are preferred over the Johnson & Johnson COVID-19 vaccine for primary and booster vaccination. Individuals ages 12 to 17 who received a Pfizer COVID-19 vaccine may receive only a Pfizer booster shot at this time.
I meet eligibility criteria for a COVID-19 booster short or additional primary series/third dose. How can I get one at Memorial Hermann?
Eligible members of our community may visit any of Memorial Hermann's walk-in clinics to receive their booster shot or additional primary series/third dose. Note: The type of vaccine (Pfizer, Moderna or Johnson & Johnson) being offered, as well as hours of operation, will vary by walk-in location. This information is listed on the walk-in clinic website. Please visit a location that offers the type of vaccine you wish to receive. Be sure to have a photo ID with you, as well as your COVID-19 vaccination card to verify the appropriate timing of the vaccination.
If I received my first series of the COVID-19 vaccine outside of Memorial Hermann, can I receive my booster shot or additional/third dose at a Memorial Hermann vaccine clinic?
Yes. Individuals who qualify for a booster shot or additional/third dose may receive their vaccination at Memorial Hermann regardless of where they received their initial vaccine series.
What documentation do I need to bring with me when receiving my booster shot or additional/third dose?
Please have a photo ID with you, as well as your COVID-19 vaccination card to verify the appropriate timing of your vaccination. No additional documentation is required.
Please note that minors will be required to have an adult accompany them to receive their vaccination. Minors do not have to show ID to receive the vaccine, but their parents/legal representatives do.
Getting Vaccinated At Memorial Hermann
Will I get to choose which COVID-19 vaccine I receive at Memorial Hermann?
Yes, individuals who receive an invitation to schedule vaccination can select a location for their appointment based on the vaccine being administered at that clinic.
Who is eligible for vaccination at Memorial Hermann?
Memorial Hermann is pleased to offer free COVID-19 vaccinations for individuals 5 years of age and older at clinics across Greater Houston. To schedule a vaccination appointment, click here. Please note, minors (individuals 5 through 17 years of age) will be required to have an adult accompany them to their vaccination appointment. Memorial Hermann locations administering the Moderna or Johnson & Johnson vaccine will only vaccinate individuals 18 years of age and older.
I received an email from Memorial Hermann saying I could schedule an appointment to receive the COVID-19 vaccine. Can I schedule an appointment for my spouse or other family member as well?
The invitation you received cannot be used by another individual. We encourage your loved ones to register for vaccination by completing Memorial Hermann's COVID-19 Vaccination Request Form. They will be notified when appointments are available for them.
I was forwarded the invitation to schedule vaccination from a family member/friend. Am I allowed to schedule an appointment using this link?
No. Invitations to schedule vaccination may only be used by the intended recipient. We encourage you to register for vaccination by completing Memorial Hermann's COVID-19 Vaccination Request Form. You will be notified when appointments are available.
I scheduled an appointment for vaccination, but I cannot find my appointment confirmation. How can I find my appointment details?
When you scheduled your vaccination, you should have received an automated confirmation text message from (281) 214-6637 or email from MHVaccination@memorialhermann.org. If you cannot find your confirmation, please call Memorial Hermann's COVID-19 Vaccine Helpline at (833) 772-2864.
I scheduled an appointment for vaccination, but now I need to cancel or reschedule. How do I do that?
We strongly encourage you to keep your current appointment date and time. However, we understand circumstances can change. If you need to reschedule your appointment, locate the appointment confirmation that was sent to you via email from MHVaccination@memorialhermann.org and click on "Cancel My Appointment." You will be able to reschedule after your initial appointment has been cancelled.
How can I ensure that upon receiving the vaccine my information will be added to the state registry?
You do not need to take action to make sure your vaccination is registered. Memorial Hermann will report all vaccinations to ImmTrac2, the statewide immunization registry. That record will contain the details of your vaccination – the brand of vaccine you received, for instance, and when you receive the second dose – and it can be accessed later by medical professionals.
How do I obtain a copy of my records showing I received a COVID-19 vaccination?
If you received your COVID-19 vaccination through Memorial Hermann, you may obtain a copy of your COVID-19 vaccination record through Memorial Hermann's patient portal, Everyday Well. This online account is accessible via the web or an app on your phone. To sign up, click here and then follow the step-by-step directions listed on the page. Once logged in, you can access your medical records, including proof of COVID-19 vaccination. COVID-19 vaccination records can be located by clicking on the "Health Information" tab, then selecting "Health Summary," and then scrolling down to the "Immunizations" section. Please note that it may take up to seven days for your COVID-19 vaccination record to appear in the "Immunizations" section of your Everyday Well patient portal.
If you need help creating your Everyday Well account, please call (713) 222-CARE (2273).
If you are unable to access your vaccination records through Everyday Well, you may also request them through the Memorial Hermann Release of Information Department. Click here for more information.
Still have questions about the COVID-19 vaccine? Fill out the form below to contact a representative from our Nurse Health Line.
Patient's First Name * Patient's Last Name * Phone Number * ZIP / Postal Code * Email Address *
Preferred Language * Preferred Method of Contact * Email Phone Call How can we help you? *
Visitor Policy & Important Announcements
Memorial Hermann's Mandatory COVID-19 Vaccine Policy
COVID-19 Vaccine Walk-In Clinics
COVID-19 Vaccine for Children
Frequently Asked Questions About COVID-19 Testing with Labor & Delivery Patients
COVID-19 Information for Patients With Cancer


text:
https://www.edge.org/conversation/jennifer_jacquet-jennifer-jacquet-shaming-at-scale
Conversation : CULTURE
Jennifer Jacquet [11.18.14]
Shaming, in this case, was a fairly low-cost form of punishment that had high reputational impact on the U.S. government, and led to a change in behavior. It worked at scale—one group of people using it against another group of people at the group level. This is the kind of scale that interests me. And the other thing that it points to, which is interesting, is the question of when shaming works. In part, it's when there's an absence of any other option. Shaming is a little bit like antibiotics. We can overuse it and actually dilute its effectiveness, because it's linked to attention, and attention is finite. With punishment, in general, using it sparingly is best. But in the international arena, and in cases in which there is no other option, there is no formalized institution, or no formal legislation, shaming might be the only tool that we have, and that's why it interests me.
JENNIFER JACQUET is Assistant Professor of Environmental Studies, NYU; Researching cooperation and the tragedy of the commons; Author, Is Shame Necessary? Jennifer Jacquet's Edge Bio Page
SHAMING AT SCALE
My name is Jennifer Jacquet. I'm an assistant professor in environmental studies at NYU and I'm interested in large-scale cooperation dilemmas. A lot of those are environmental in nature. I wonder about what it's going to take to leave 1,700 billion barrels of oil in the ground, or half the fish in the ocean, or to remove nitrous oxide from the atmosphere so that we don't deplete the ozone.
The interesting thing about conservation, and science in general, is that it's moving into the social sciences and into questions about human nature. You would say, especially someone like Josh Knobe might say, well, that's not that interesting because a lot of fields, including philosophy, are doing more empirical work. Gender studies are also moving more into the social domain and empirical data collection. The same pertains to African-American studies. But the interesting thing here is that with conservation science it was epistemologically and institutionally a discipline in the natural sciences, rather than the humanities.
I find this move interesting and also challenging for a lot of hardcore biologists and ecologists who have traditionally dominated the field to recognize that the most important interrelationship is not between the plants and animals, or the animals in the ecosystem, but between humans and the environment. I view there being a big wave of environmental social science coming on board, and I'm part of that wave.
My supervisor for my PhD was a fisheries biologist. He did important work early on in basic science on oxygen and growth level, population ecology, and then only later in his career, realizing the problems out there in the ocean, turned more toward social questions, about subsidies, and the affects of marine reserves, and had this more human-dominated view. That's one exciting wave in social science, at least in the realm of conservation.
One of the first disciplines to get on board with this has been psychology, so we now have conservation psychology and environmental psychology. They've done important work. The American Psychological Association released a report in 2009 about the effects of climate change on psychology and vice-versa. But I don't think psychology is going to be the only social science we need in this pursuit, because of the focus on the individual, and I'll get to that in a moment.
My reason for turning to social science from the natural sciences is because I became interested in guilt as a motivation for changing one's behavior, for changing one's decision-making, and I saw guilt being prevalent in environmental issues, such as over-fishing, climate change. That interest in guilt led to shame, to the point where people started describing me as somebody who worked on fish and shame, which was just a little bit weird, but I hope to tie that all together for you today.
Backing up to some of that more basic or even humanities type research on guilt, it's argued that guilt is a relatively new phenomenon, in general. It's primarily a Western phenomenon, linked to the rise of individualism as a characteristic, and more prevalent in the West than the East. In some Eastern cultures they don't even have a word for guilt, and there are others who argue and philosophers who argue that it's also linked to the rise of abstract thinking.
My own view on guilt is that it's highly dependent on how much time you get to spend alone. I think that when you have zero chance of spending any time alone in your society, you're very unlikely to have strong feelings of guilt every day, in part because I view guilt as defined—and there are lots of arguments, and you all know these better than I do, definitions about what guilt or shame really mean—but guilt is internalized, and the only person you're answering to is your own self. I view guilt as the cheapest form of punishment there is. It's self-punishment, and you prevent the group from having to punish you by either cutting yourself off from doing the act, to begin with, or paying some sort of penance afterward.
Shakespeare used the word "guilt" only 33 times. He used the word "shame" 344 times. So when we start thinking that it's just a Western thing, we should also note that it's even more modern than just being a Western phenomenon. My own particular interest is in environmental guilt, which I see this rising a lot, basically beginning in the 1980s, and I tie this to a switch from a system that was focused on changing a supply chain and production of chemicals or bad products, to more a demand-focused side strategy.
With that demand focus strategy, the focus on the individual, guilt was an easy low-hanging way of getting people to engage with the issues. Of course, there's a big threshold problem there. Because it's linked to a switch from the focus on supply to the focus on demand, it means that its power is very limited.
If you ask does this behavior scale, I would argue, no it doesn't scale. Does the U.S. feel guilty for doing something? Does BP feel guilty for the Gulf Oil spill? By the very definition of what guilt is—an internal regulation of one's own conscience—it implies, at least to me, that it does not scale to the group level; although, you have these trends, like survivor guilt or collective guilt, that call this into question.
I am interested in social problems, so maybe we should focus on the types of social emotions that might scale, and not just social emotions, but social tools, and that's why I got interested in shame as a tool, which is separate from shame as an emotion. We could all disagree here about what shame is as an emotion. A lot of people agree that it requires some sort of audience, but some don't. Some people argue it's a sense of your whole self, or as guilt is just based on the transgression itself. But I want to focus on shame as a tool, as a punishment, and situate it within a larger body of punishment.
I would like to distinguish shame, starting off, from transparency. A lot of people confuse them in the popular media, thinking that they're the same thing. Transparency exposes everyone in a population, regardless of their behavior, whereas shame exposes only a minority of players, and this is an important distinction. Both shame and transparency are obviously only interesting if the distribution is not uniform. So we have to have some variability in there; otherwise, we're really not interested in the behavior. I want to argue, too, and one of the points I make in some recent work, is that shame is more effective the larger those gaps are, not just between existing behaviors, but between what we think should happen and what is actually happening.
Shame and transparency are different. Shame, in fact, even though we all have a knee jerk reaction to thinking it's a terrible tool, can be more protective than transparency. We have these groups like the Sunlight Foundation that say we want to expose all politicians' behavior, and actually, I argue that maybe only exposing the worst of the players' behavior can be more beneficial than exposing everyone.
The way that I first started working on shame was to look at public goods games, these cooperative dilemmas that have already been talked about, where you can either donate money or not, and then that money is doubled or tripled and redistributed evenly to all players, so there's that tension between the individual and the group. What's interesting about punishment in these games is that the way it's been operationalized is entirely monetarily, so you play a little bit of money, and you extract a bigger amount of money from the person you're punishing. This is a very one-dimensional way of looking at punishment.
We should get a little more creative about the way that we operationalize punishment in these games. Of course, it's very hard. Maybe we could shock people. We can't put them in prison. We can't kill them. That wouldn't get past an ethics review. But these are the forms. We have these kinds of deprivations: we can either remove life, liberty, physical safety, resources, or reputation.
In our experiment we told players at the start of the game that the two players that donated least out of six would be exposed at the end of the game. That was the only threat of punishment they received, this burden of social exposure, what we would call shame, again, as a tool, rather than an emotion. We didn't even measure how they felt. We didn't care how they felt, frankly. We were caring about the behavior that manifested, and, again, that's because I don't come from a psychology background. I'm interested in a more economic side of things, especially with the scaling effects.
What's interesting is that we have these forms of punishment monetarily, and no one would ever question those ethically. But after our experiments came out, I was blindsided by the fact that some people didn't agree with the experiments from an ethical perspective: that we would expose these two players to the group for having contributed the least—despite them having known at the beginning of the game that this was the case. It's interesting to me that people would say this isn't ethical, because we use this form of punishment all the time in society in all different sorts of ways. If we view it unethically in the academic environment, and yet we're using it a lot in society, it makes it very hard to make any sort of empirical statements about what we should or shouldn't do in the future. Either we should get rid of social exposure entirely in society, or we should test it in a lab and see how it works, but we can't continue this disjuncture between having lots of it in real life and nothing in the lab. What we were able to show is that the threat of shame increased cooperation by about 50 percent. You don't get a lot of movement because there's a binary choice between whether or not they want to give one dollar or not in these games, but I find that that's interesting, because unlike the other forms of punishment in these games it was just reputation. It was only that they had to stand up in front of the crowd at the end. Nothing more. But we did recruit students, and this would be hard, again, in the replication. They would have to read very closely who came from the same class, so they did know that they would see one another again in the future, which matters, of course, to ultimately maybe more resources or reputational effects down the line.
One way in which social science can also push the field is to look at these different forms of punishment in cooperative dilemmas or otherwise, in part, because they do scale, and also because, again, we have them widely used in society, but not actually looked at empirically.
In my work I have tried to look for studies that used shame in various ways, maybe not in a lab experiments, but there were studies that used it in natural field experiments, especially with voting behavior, and they were interesting because they find that shaming actually leads to the greatest change. The experiments involved sending letters that said here's your voting record and here's your neighbor's voting record, and after the next election we're going to send you an updated version of this. They were basically threatening exposure to your neighbors of your own voting behavior, and this single piece of mail actually increased voting by eight or nine percent, and normally no piece of mail works better than one percent.
On the other hand, with one of the shaming conditions, so many people called and were angry about it that ultimately they decided not to do part of the experiment, which in this case was to publish the names in the newspaper. It shows that shaming might be very effective as a tool, but very impermissible as a means of changing society. This is what I'm looking at now, ways in which you can make shaming more effective as a tool, which, again, you have to just be completely agnostic about. And then there's the bigger question that is more on the normative side of things, which is just because it's effective does that mean it's acceptable in society? Does that mean that we want to use it?
A real-world case, in which shaming was very effective, was when Amnesty International went after the U.S. in the international media for executing juveniles. Until the law was changed in 2005, we were one of the only countries, certainly the only Western country that is executing juveniles. Amnesty International conducted a large-scale shaming campaign that worked, which points to a few things.
Shaming, in this case, was a fairly low-cost form of punishment that had high reputational impact on the U.S. government, and led to a change in behavior. It worked at scale, one group of people using it against another group of people at the group level. This is the kind of scale that interests me. And the other thing that it points to, which is interesting, is the question of when shaming works. In part, it's when there's an absence of any other option. Shaming is a little bit like antibiotics. We can overuse it and actually dilute its effectiveness, because it's linked to attention, attention is finite. With punishment, in general, using it sparingly is best. But in the international arena, and in cases in which there is no other option, there is no formalized institution, or no formal legislation, shaming might be the only tool that we have, and that's why it interests me.
It makes sense to me that evolutionarily speaking we would need harsher forms of punishment, because if shaming was perfectly effective, if shaming was the ultimate tool, we wouldn't throw people in prison, behead them, or anything like that. It is, I would argue, a hit or miss type tool. It can really work, or not work well, depending on a lot of things that I'm trying to explore in doing research which looks at what makes shaming more or less acceptable, and what makes it more or less effective.
THE REALITY CLUB
DAVID PIZARRO: The features that make shame a handy tool also in some ways are what make people very afraid of it. For instance, in order to make something legal there are usually procedures you have to go through, where you can get most of the members of society to agree that this ought to be outlawed. Shame can be used as a tool to enforce something that a wide segment of people might not believe, the person themselves might actually not believe, so unlike with guilt you don't have to endorse that you did something wrong to experience shame. And it is, as you pointed out, powerful. So we get things like slut shaming, right?
JACQUET: Sure.
PIZARRO: And just because any group of people can decide that you ought to feel shame, they can exert this social pressure that could be—as you rightly point out because it's such a fundamental part of our human nature—arbitrary, capricious, and in the hands of people who could just decide on a whim that they don't like you. The tradeoff and why many people may be against it and another problem is you could have, for instance, is that with the Internet you have this vigilantism of shame where it's such low cost to shame somebody else that the fear is of tyranny, this particular kind of emotional tyranny that doesn't seem … like, strangers can't make me feel that guilty, but they can sure make me feel shame. Is there anything to the thought that as effective as it might be, we should just get rid of it?
JACQUET: Get rid of it? Yes. Absolutely. The main argument here is that shaming undermines human dignity. The role of the state, or one if its goals should be to protect human dignity, and, therefore, we should outlaw shaming for individuals entirely, something I am not that opposed to.
PIZARRO: Well, not laws. I'm saying as like good people, like a law … in fact, without laws …
JACQUET: You're saying why not just have a law instead of the shaming?
PIZARRO: No. I'm saying that as human beings we should frown on the use of shame. I don't know whether laws can change people.
JACQUET: Imagine the type of law that you would need, especially in the digital space, and how it would be operational. How it would affect what we would argue would be free speech, or activism, or because it's just words. That's the crazy power of shame. I am in favor of the state not being involved in shaming individuals. I don't know about other people. It's very hard to control behavior. There's some level of decency that should speak to this. That's why I'm interested in using shame at the group level.
There are cases, in fact, with individuals in which it's warranted. We had talked about civil servants earlier, and things like that, and certainly there are very strong arguments. The argument I find even more compelling is the cost on the audience. The reason why shame works is that there's an audience that you imagine is endorsing this position, and for shame to really work there has to be an audience that's heckling. This can be some kind of imaginary audience, such as a bunch of fake Twitter names. Again, all of us, as in the antibiotic case, would benefit from shame at least being used very, very sparingly, even for our own just audience-member perspective, because shame demands our attention, let alone the fact that we could eventually become its victim. But while shame is absolutely the last resort, I don't think we should take it off the table entirely.
DAVID RAND: As an opposite of Dave's question, I had a thought on how to do it better, more effectively, that is.
LAURIE SANTOS: Good David and Bad David.
RAND: Like the case with the voting study, which is cool, and what we've been doing in our observability field studies, with the blackout prevention. They both have potential for the same thing, because basically, while you can question whether it's shame or a celebration of people doing good things, either way it's reducing privacy and making people's behavior observable to people around them, right? It's a huge thing that if it's obvious that the reason that you're doing it is to shame them, it pisses people off. But there's ways that you can provide exactly the same information with a different purported purpose, and it can be effective without pissing people off.
In the case of the blackout prevention study, it wasn't a case of putting your name and address on the signup sheet so that the other people will see you, it's just that when you have a signup sheet, it seems like a natural thing that you're going to have to put your name and address on it. I'm sure that for people in the observability condition, it never occurred to them that that was being manipulated. Or, with other kinds scaling versions of that, i.e., if you want to have something where you advertise on Facebook that you did some energy-improving remodeling of your house, or something like that, we can't say, "Put this badge on your Facebook page to show off to people how good of a person you are," because people will be unhappy. But instead we can say "People don't know about this program, so if you post this badge other people will know, and that will help spread the word." I guess it's a little bit harder with shaming. Perhaps that's another question. What do you think about shaming versus celebrating?
JACQUET: The observability stuff, even the eyes example, are cool and interesting experiments, but it turns out the effect wears off after like 12 months, without any real punishment coming in, even CCTV effects. Regarding observability, I would argue you can get these spikes in improvement, but for the long term it doesn't necessarily play out in the same way. And also, with the blackout stuff, the cooperative dilemma is quite different.
Then, for instance, let's look at the tax delinquent problem. There are tax delinquents in every state. If you can imagine some system of observability or transparency it would be unfair if you paid your taxes on time—if there was a list that said: paid taxes on time and listed the amount. A lot of us don't want people to know our salaries, or our taxes. But in the case of California they say: we're going to publish online the names of tax delinquents, and we're going to actually send them a letter in advance, so they have six months to avoid being posted, which is also key. The threat of shame is more effective than the act of shame, because once you've shamed the delinquent you create a reputational effect where people think the damage is done, so why not continue to defy the norm.
But on top of that, California only exposes the top 500 worst. It's actually a protective. It's not transparency. It's not every tax delinquent. It's just the very worst. I would argue observability in this case to the general population would be very undesirable, but the shaming option is perfectly acceptable. That's where with the blackout system there's less variability in behavior overall—the tax example is almost like a power law distribution.
RAND: I mean to me what you just said is observability. All observability means is making some information about what people do salient or available to other people.
JACQUET: Sure. I'm just using observability as a synonym for transparency, where you expose everyone's behavior, and shaming as a targeted exposure on the minority of bad actors, which is a key distinction in the way the policies play out. It's really different.
RAND: Right. But then whether shaming the bad actors or celebrating the good actors is going to be more effective probably depends on which is more common. In the blackout study we had about five percent of people signing up.
JACQUET: But imagine celebrating the good actors in the tax issue. You would never do this, right?
RAND: Exactly, because that's a situation where that's the very common …
JACQUET: It's not that it's very common. It's that …
PIZARRO: That's what Molly was saying about above and beyond.
MOLLY CROCKETT: Yes. Well, not just that, but this very question has been worked out theoretically by Roland Benabou who has looked at, in a theoretical, mathematical sense, which is more effective, celebrating or shaming, and it turns out that it really depends on the base rate. He gives the example of hybrid cars. Initially, hybrid cars were quite rare, and so incentives worked really well and celebrating worked really well, because you get a free pass to drive in the carpool lane, so on and so forth, and that encourages take-up of that behavior. But then once it becomes widespread then the optimal strategy shifts towards shaming those who violate the norm.
JACQUET: But it depends on more than just the distribution curves as well. You can imagine that with climate change, we could honor the countries that are actually doing something about it. But without everybody on board it doesn't matter, because it's a threshold collective risk dilemma. Therefore, the type of problem actually defines which one you go for rather than just the distribution. That's why the two probably intersect in an interesting theoretical way.
FIERY CUSHMAN: We've addressed several times today this question of do you want to just achieve a behavior, or does it matter what the psychology underlying the behavior is, and we've talked about that in terms of the agency of the individual and what counts as truly moral behavior, but there's also just utility consequences.
I could keep myself awake by drinking a delicious latte, or by poking myself in the eye continuously. Maybe poking myself in the eye is a better way of keeping myself awake, but the latte tastes better. And one might also think that being in a society that focuses on celebration to the maximum extent possible and uses shame as little as possible is just going to make for a happier citizenry, even if there's a slight hit that you take in terms of the behavior that you want to maximize.
JACQUET: That's where the issue of human dignity gets interesting, because yes, at the psychological level that's probably true, and shame is this horrible, terrible thing that we hope to all avoid, but at that group level, where you could argue that corporations don't have the same level of human dignity, or Congress doesn't have human dignity, or the U.S., or Yemen, or whoever, then things get a little more interesting, because then you're saying this is just about reputation, and we don't mind hurting their dignity, because the people can come or go from that group as they please, and because of that you can say it's an effective tool, and we might have taken it off the table for these psychological reasons that don't apply at scale.
JOSHUA KNOBE: I'm following-up on Fiery's question about what is it that makes us so resistant to the use of shame as a method. Consider your case of tax evaders. Suppose someone said: "We have two options. One is to put tax evaders in prison, and the other is to put billboards on the street -- for instance, a big picture of the tax evader." And then suppose that the tax evaders all prefer the billboard; they would much rather have a billboard with their picture saying that they're a tax evader than to go to prison. I would still feel terrible about it. It still seems so demeaning to have the billboard. You don't feel like there's something drawing us away from shame that goes beyond …?
RAND: Prison is pretty bad.
KNOBE: In a sense, as a society, we don't want to be the society that has the billboards?
JACQUET: I do feel that way, in part because again, as the audience, I'm asked to be part of that, I'm asked to be complicit in the punishment, and a good democracy was based on the idea that the state has the only authority to punish at severe levels.
SARAH-JAYNE BLAKEMORE: What about the relationship between religion and shame? Because that seems like it hasn't been mentioned, but some religions seem like institutionalized shame.
JACQUET: Sure. The Scarlet Letter was a product of the church itself. Maybe the government was more in favor of what God thought was right than what the majority thought was right, but it hurt human dignity, and there are long-term consequences that aren't great for individual psychology.
BLAKEMORE: They still embraced religion.
JACQUET: This is what happens when you lack formalized punishment. It's what Foucault argued in Discipline and Punish, with prisons. When you could send someone away to prison this made a lot of shaming punishments go away, because there was another formalized mechanism for punishment that we didn't have before. We didn't have that liberty option for deprivation. Reputation was one of the only forms aside from life, from cutting somebody's arm off, or taking their house away, etc.
And this is why shaming is used in the tax case. At the federal level you can go to prison, so there is no shaming option there, but at the state level all they can do is confiscate second homes and luxury vehicles, and in the time it would take for them to get that legislation changed, because there's so much resistance to anything related to legislation and taxes, anything, they said here's our stopgap. We're going to use reputation, and we're going to get back $340 million, which makes it totally worth their while, as it only costs them $180,000 a year to run.
In our society we ideally want these punishments formalized, and we want due process in all these things, but in the interim, it's an interesting sort of group punishment that's accessible to everyone, which is the scary thing about it.
HUGO MERCIER: I have a quick question about this scaling that you mentioned, how it works exactly, in that I couldn't imagine how shaming would work if no single individual feels ashamed. That is, Congress can't feel shame obviously, so if any individual congressman or congresswoman doesn't feel shame, then why would they do anything?
JACQUET: I'm not even certain that shaming's effectiveness is because of an emotion. It could just be linked to reputation and the fear of losing resources down the road. There are a lot of psychopathic people who would still respond to shame out of the fear of them being ostracized, or out of fear of something harsher later.
Assistant Professor of Environmental Studies, NYU; Author,...
Beyond Edge
Jennifer Jacquet's Home Page
DLD Women 2012: The Scarlet Internet
DLD Interview: Shame Online
Is Shame Necessary?: New Uses for an Old Tool
By Jennifer Jacquet Hardcover [2015]
Sarah-Jayne Blakemore, Molly Crockett, Jennifer Jacquet, Michael McCullough, Hugo Mercier, L.A. Paul, David Rand, Lawrence Ian Reed, Simone Schnall [ 11.18.14 ]
Helena Cronin, Chiara Marletto, Jennifer Jacquet, Steve Jones, Molly Crockett [ 11.6.14 ]
Part II: Edge, Live in London 2014
A Conversation With Helena Cronin, Chiara Marletto, Jennifer Jacquet, Steve Jones, Molly Crockett, Hans Ulrich Obrist [ 11.6.14 ]
A Talk By Jennifer Jacquet [ 11.6.14 ]
DELAYED GRATIFICATION HURTS CLIMATE CHANGE COOPERATION
Jennifer Jacquet [ 11.4.13 ]
A Rough Mix: Brian Eno & Jennifer Jacquet	An Edge Conversation
An Edge Conversation
Brian Eno, Jennifer Jacquet [ 11.22.11 ]
Sci Foo 2011
Googleplex, Mountain View, California — August 12-14, 2011
Frank Wilczek, Jennifer Jacquet, Timo Hannay [ 9.11.11 ]
Is Shame Necessary?
Jennifer Jacquet [ 7.13.11 ]
Edge-Serpentine Gallery-MAPS FOR THE 21ST CENTURY
Special Events [ 10.16.10 ]

redpajama_set_name: RedPajamaCommonCrawl


text:
Catch a Fallen Star: excerpt
By Lawrence Grobel on February 26, 2012 in Books
He felt like crying. Who could he call? Kevin Costner? Oliver Stone? Gary Oldman? Denzel Washington? He had their numbers but what would he say to them? Wanna play some ball? Go fuck women? Be friends? They had their own problems, didn't need him. And he didn't want to be anybody's problem. Why did it have to be so lonely being an actor? A movie star. Former star. Current failure. The Invisible Man. That's what he should revive. Wouldn't have to see him at all.
"Layton? You in here?" Amy walked groggily into the dark room. "You scared me," she said when she saw his outline. "What are you doing in the dark?"
"Thinking dark thoughts."
"Where'd you take the kids?"
"What if I didn't come here tonight?"
"They know where the food is, they can feed themselves."
"I'm going to have you committed."
"Swell, I could use a vacation."
"You just had one."
"My mother's no vacation. She makes me very nervous."
"Don't turn on the light."
"I want to see you."
"I haven't changed."
"This gives me the creeps."
"Go back to bed."
"I've got a headache."
"Will you massage my neck?"
"What do you want, Layton?"
"A life."
"You've got that."
"Is that what you call this?"
"What about me? What have I got? You were no prize."
"I don't care about you. You better start caring about yourself."
"I make out."
"That's not what I mean."
"I'll survive. You're the one who's got to worry."
Layton sighed. If he could snap his fingers and make her disappear forever he'd do it. Was this the burden he was meant to carry like Sisyphus? Is Amy what existential meant? Could he kill her and put her out of her misery? Oh my Jesus.
"There's no aspirin in the house," Amy said.
"Take a vitamin."
"Could you go get some?"
"It's two-and-a-half miles down the canyon. I don't want to go out anymore. I've been out."
"Then I'll go."
"Please. My head. My eyes, just behind my eyes. I can't drive like this."
"Christ, Amy, I should punch you too."
"Too? Did you hit the children?"
Layton stood up, glared at her in the dark, and walked out. She asked where he was going and he answered he'd be back.
About Lawrence Grobel
View all posts by Lawrence Grobel →
You Show Me Yours: a Memoir (Introduction)
Begin Again Finnegan: excerpt
Harlan Ellison: The Don Rickles of the Literary World
Black Panther Power!
RHINOS & TIGERS & WRITERS, OH MY! Thoughts on the Freelance Life
DOLLY PARTON, CHARLIE MANSON, & ME
To Knead, Perchance to Twist–Ay, There's the Rub!
RIP Zsa Zsa, You Lived a Long Life
Returning to Paradise: Revisiting Marlon's Island at The Brando
Where Have You Gone, Patty Hearst?
Having a Catch
Tweets by @LarryGrobel
© 2014 Lawrence Grobel. All Rights Reserved.
Designed by Host Pond


Craftster Community > CITY GUIDES FOR CRAFTSTERS > U.K. AND IRELAND > SCOTLAND > 10% off yarn!
Just to let everyone know that Mandors have 10% off all yarn with this voucher during our sale period.
Please feel free to pass the voucher on to your friends.


On Saturday 31 March, Nauru Airlines Boeing B737-300 VH-XNU was spotted arriving into Mackay Airport, touching down direct from Brisbane as RON800.
After around an hour on the ground, VH-XNU was then noted departing Mackay for Cairns as RON901.
It is believed that VH-XNU transported players and support staff of the local Mackay Cutters Queensland Rugby League (QRL) Team to Cairns where they were to play the Cairns-based Northern Pride QRL Team in the latest round of the Intrust Super Cup.
Following the game on Saturday night, information suggests that the players and support staff will return to Mackay with VH-XNU expected to make a midnight arrival back into Mackay Airport late on Saturday 31 March / early on Sunday 1 April.
As we've mentioned in the past, Nauru Airlines (the trading name of Nauru Air Corporation) and formerly known as 'Our Airline' and 'Air Nauru', is the national airline of the Republic of Nauru. It currently operates scheduled international services from Nauru to other Pacific Islands and Australia. Nauru Airlines also operates various charter flights to locations in Australia, Asia, New Zealand, South and Central Pacific.
Presently, Nauru Airlines operates a fleet of four Boeing 737-300 aircraft, each configured in a 130-seat / 2-class layout that service Brisbane (Australia), Majuro (Marshall Islands), Nadi (Fiji), Nauru (Nauru) and Tarawa (Kiribati). A lone Boeing 737-300F is also operated.
Sincere thanks to local plane spotters 'JM' and 'TM' for taking the time to capture and send through these great photos of a great visitor to the Sugar City!
On Saturday 31 March, Queensland Government (QGAir) Rescue (State of Queensland) Agusta AW139 helicopter VH-ESH was noted ferrying South from Townsville to Archerfield via Mackay and Gladstone Airports.
VH-ESH was heard using the radio callsign of "Rescue 500" - the usual callsign of the Archerfield-based QGAir Rescue helicopter that flys missions around the South-East corner of the state.
As posted below, fellow QGAir Agusta AW139 VH-EZJ flew North to Townsville at the start of last week as "Rescue 500" and was noted assisting with the rescue and recovery efforts after Tropical Cyclone Nora made landfall. I presume the helicopter 'swap' was to allow VH-ESH to now enter the maintenance hangar.
Former Heli-Aust Whitsundays (Mackay Helicopters) Bell 222 VH-TOR Departs Australia for good with PNG Rego P2-HOT!
It appears that a former Central Queensland-based helicopter has finally departed Australia for good following a period of storage at the Whitsunday Airport at Shute Harbour.
Former Heli-Aust Whitsundays (Mackay Helicopters) Bell 222 helicopter VH-TOR was recently noted as being cancelled from the Australian aircraft register and being placed on the Papua New Guinea aircraft register. It appears to have ferried out of the Whitsundays via Cairns and and points North sometime during March.
The Bell 222 has been placed on the Papua New Guinea aircraft register as P2-HOT and looks to be registered to Manolos Aviation of New Rabaul in PNG.
Fellow former Heli-Aust Whitsundays (Mackay Helicopters) Bell 430 helicopter VH-HIA appears - at this stage - to be remaining in storage at the Whitsunday Airport at Shute Harbour.
It has been reported that it too will eventually head to Papua New Guinea so it will interesting to see if it heads to the same operator!
A 'new' Qantas Airways aircraft has made its first visit to Hamilton Island Airport after recently being re-registered and re-entering service with the airline.
On Friday 30 March, Qantas Boeing B737-800 VH-VZH was noted operating into Hamilton Island Airport on the scheduled QFA870/871 service from and back to Melbourne (Tullamarine).
The B737-800 was originally ordered by Qantas back in 2009 and was registered VH-VZH in September of that year. It was accepted by Qantas in early October 2009 and at that time too, VH-VZH also carried the New Zealand flag and 'ZQC' on the nosewheel doors.
Soon after its arrival into Melbourne, the aircraft entered the New Zealand aircraft register as ZK-ZQC during the latter part of October 2009 with Jetconnect Ltd in Auckland, New Zealand as the registered operator. ZK-ZQC was named 'Katherine Mansfield' and then operated its first Qantas Jetconnect revenue service from Melbourne (Tullamarine) to Auckland as QFA25 on Thursday 22 October 2009.
ZK-ZQC operated its final service for Qantas Jetconnect on Thursday 8 March when it arrived into Brisbane from Auckland as QFA124. The aircraft was subsequently cancelled from the New Zealand aircraft register and was then re-registered as VH-VZH, again with Qantas as the registered operator.
VH-VZH entered service with Qantas on Friday 23 March. VH-VZH is pictured above arriving into Adelaide on its first day of operations.
Nice Helicopters Ferry Through CQ Airports on Good Friday - UPDATED!
It was a 'Good Friday' for plane spotters with at least four nice helicopters being noted passing through Central Queensland Airports on Friday 30 March.
Perhaps the nicest was Aerospatiale 350B3 Ecureuil Squirrel Helicopter PK-FUI which arrived into Rockhampton Airport from Cairns via Townsville. As the photo below shows, it once wore the stunning colours and titles of Hevilift.
It appears as though PK-FUI has stayed at Rockhampton Airport, although I am unsure as to whether it still wears this attractive livery.
UPDATE! PK-FUI looked to depart South from Rockhampton Airport early on Saturday 31 March. There are reports that it has a revised livery.
FURTHER UPDATE! With sincere thanks to local plane spotter Leroy, we can share this great photo as PK-FUI passed through Townsville Airport - looking quite nice in the revised Hevilift titles and livery.
Also passing through Rockhampton Airport (again) was McDermott Aviation / Heli-Lift Australia Bell 214B-1 Big Lifter helicopter P2-MSA.
P2-MSA flew through Rockhampton Airport last weekend - as shown above - and it appears that today it was returning south to its Cooroy base on the Sunshine Coast after operating in Far North Queensland after supporting relief efforts following the landfall of Tropical Cyclone Nora.
UPDATE! P2-MSA in fact overnighted at Rockhampton Airport and departed for Cooroy on Saturday 31 March.
Also heading home to the Sunshine Coast, but on Thursday 29 March, was fellow McDermott Aviation / Heli-Lift Australia Eurocopter AS365N3 Dauphin 2 helicopter N82MD. It was noted at Gladstone Airport before continuing to Bundaberg where it looked to stay for the night. On Friday 30 March, it continued to the Sunny Coast.
UPDATE! On Saturday 31 March, the third and final of McDermott's helicopters that assisted in Far North Queensland was noted to also return 'home' to the Sunshine Coast with Bell Textron Helicopter 214B-1 Big Lifter helicopter VH-SEK noted flying South via Mackay, Rockhampton and Gladstone Airports.
Also passing through Gladstone Airport but early on Friday 30 March was recently re-registered Aerospatiale AS.350BA Squirrel helicopter VH-EGI. It was heard to depart to Townsville where it appears to have recently taken up residence with Koolardie Aviation.
Finally, a rare military movement on Good Friday with Australian Army NH Industries MRH-90 Multi-Role Helicopter A40-030 "Rogue 33" passing through Rockhampton Airport.
It looked to fly up from RAAF Base Amberley and completed airwork in the Shoalwater Bay Training Area (SWBTA) before landing at Rockhampton Airport for a short time. A40-030 eventually returned to Amberley.
On Friday 30 March, Higher Cause LLC (USA) Dassault Falcon 2000EX bizjet N222JE was noted arriving into Hamilton Island Airport. It looked to touch down from Cairns where it had earlier arrived from Honiara in the Solomon Islands.
At the time of writing, it appears to be staying for at least the night.
Meanwhile, also parked at Hamilton Island Airport is the familiar sight of Homada Pty Ltd Cessna 560XL Citation XLS bizjet VH-XCU which arrived into Hamo on Thursday 29 March from Melbourne (Moorabbin) via Melbourne (Essendon).
The semi-regular closed charter flights we see call into Rockhampton Airport from and back to the Cairns area have happened again this week with Regional Express (REX) SAAB 340B VH-ZLC noted arriving into Rockhampton Airport from Cairns as RXA9907 late on Tuesday 27 March.
After staying for the night, VH-ZLC departed Rocky and returned to Cairns before continuing further to Horn Island as RXA9908 early on Wednesday 28 March.
Meanwhile, it is worth noting that the other 'semi-regular' light General Aviation (GA) visitors to Rockhampton Airport that also visit around the same time as the REX SAABs were again noted at Rocky this week. Townsville Airlines (Flightech Air Logistics) Cessna 402C VH-JOH and Beech B200 King Air VH-WZN were both noted completing afternoon flights from Normanton and Cairns respectively to Rockhampton Airport arriving late on Wednesday 28 March.
After overnighting, both VH-WZN and VH-JOH also departed back to Cairns early on Thursday 29 March.
There are suggestions that these flights are charter flights for school children from Cairns and Far North Queensland who attend schools in Rockhampton. They would be returning home given that school holidays start today!
Finally, a couple of other interesting light General Aviation (GA) aircraft to be noted visiting Rockhampton Airport this week have included McDermott Aviation Group / Machjet International Beech B200 King Air VH-MWZ which arrived from the Sunshine Coast and later departed to Townsville on Tuesday 27 March.
While on Wednesday 28 March, Proserpine-based Piper PA-34-200T Seneca VH-HKQ arrived into Rockhampton Airport from Mackay and later departed home to Proserpine (Whitsunday Coast) Airport. And Australasian Jet (Ausjet) Cessna 404 VH-AZU was noted arriving into Rocky from Melbourne (Essendon).
UPDATE! On Friday 30 March, VH-AZU returned to Essendon. It was noted completing aerial survey work around Blackwater and Middlemount on Thursday 29 March. A quick trip!
American Registered Bombardier BD-700-1A10 Global 6000 Bizjet N60XC at Emerald Airport Once Again - Plus More!
Visiting Emerald Airport once again on Wednesday 28 March was American registered Bombardier BD-700-1A10 Global 6000 bizjet N60XC. It was noted making a day-trip to Emerald Airport, arriving from and then later departing back to Brisbane.
The sleek bizjet is becoming a semi-regular visitor to CQ having made several visits during different times over the last year or so, including at least three visits to Emerald and Mackay Airports so far in 2018.
Meanwhile, a couple of other corporate bizjet and turboprop aircraft were noted visiting various CQ Airports also on Wednesday 28 March.
LifeFlight (Aeromed) LearJet 45 bizjet VH-CXJ "Ambulance 452" was noted at Mackay Airport completing a medical evacuation flight. It arrived from Cairns and later departed to Brisbane.
Of the corporate turboprop aircraft to visit Central Queensland on Wednesday 28 March, I spotted Brisbane-based Pesca Aviation AeroCommander 690-A Turbo Commander VH-ATF at Clermont Aerodrome. It had earlier arrived from Archerfield and Bundaberg and looked to continue to Mount Isa.
UPDATE! On Thursday 29 March, VH-ATF departed Mount Isa for Longreach Airport before returning to Archerfield.
While also noted at Bundaberg Airport on Wednesday 28 March was Pegasus Air (South Australia) Pilatus PC-12/47E VH-JMU which arrived from and later departed back to Bankstown via Sydney and Archerfield, Victorian-registered Partenavia P.68B VH-PNU visited from Archerfield - where it seems to be presently based and Cirrus SR22 VH-VCD arrived from Kingaroy and later departed to Toowoomba.
On Tuesday 27 March, Royal Australian Air Force (RAAF) Beech B350 Super King Air A32-426 "Dingo 36" was noted touching down at Rockhampton Airport from Townsville. After a short while on the ground, it departed to the Sunshine Coast.
During the afternoon, A32-426 was then noted again flying into Rocky from the Sunny Coast before it then departed back to Townsville.
Meanwhile, also on Tuesday 27 March, fellow RAAF Super King Air A32-671 "Dingo 33" was noted departing Emerald Airport also heading to Townsville.
Finally, as the sun was setting on Tuesday 27 March, a pair of Australian Army NH Industries MRH-90 Multi-Role Helicopters were noted completing airwork around Hamilton Island and parts of the Whitsundays before flying to Townsville. It is believed they were A40-017 "Kraken 1" and A40-041 "Kraken 2".
Also spotted at Gladstone Airport on Monday 26 March was this attractive Cirrus SR22 G6 Australis Premium VH-ACH.
The smart little Cirrus has recently taken up residence on the Sunshine Coast and over recent days has been noted flying from there up to Gladstone Airport via airwork around various parts of the Fraser Coast including Maryborough and Bundaberg.
On Monday 26 March, Queensland Government (QGAir) Rescue (State of Queensland) Agusta AW139 helicopter VH-EZJ was spotted ferrying North from Archerfield via Gladstone and Proserpine (Whitsunday Coast) Airports to Townsville.
VH-EZJ was heard using the radio callsign of "Rescue 500" - the usual callsign of the Archerfield-based QGAir Rescue helicopter that flys missions around the South-East corner of the state.
I presume it has ferried to Far North Queensland to provide support and to help with the rescue efforts that could be needed when Tropical Cyclone Nora makes landfall.
Currently, fellow QGAir Rescue Agusta AW139 helicopters VH-ESZ and VH-ESH remain based at Cairns and Townsville respectively, while QGAir Rescue Bell 412 helicopters VH-ESB and VH-ESD have also been noted operating around the Townsville and Cairns areas respectively over the last few days.
A nice trio of McDermott Aviation / Heli-Lift Australia helicopters were also noted and spotted passing through Central Queensland Airports over the weekend while heading up to Far North Queensland to provide support and to help with the rescue efforts that could be needed when Tropical Cyclone Nora makes landfall.
On Saturday 24 March, McDermott's newest Bell Textron Helicopter 214B-1 Big Lifter helicopter VH-SEK was noted flying North from their Sunshine Coast (Cooroy) base to Rockhampton and Mackay Airports. It was noted flying into Townsville and Cairns on Sunday 25 March.
VH-SEK was joined at Cairns on Sunday 25 March by fellow Bell 214B-1 Big Lifter helicopter P2-MSA which was spotted departing Rockhampton Airport for Mackay and points North after it too had earlier arrived from Cooroy.
Meanwhile, also on Sunday 25 March, I was lucky enough to capture some photos of McDermott Aviation / Heli-Lift Australia Eurocopter AS365N3 Dauphin 2 helicopter N82MD as it popped into my local airport at Clermont Aerodrome. It too was heading to Far North Queensland to provide support after TC Nora.
N82MD looked to arrive directly from the Sunshine Coast and after taking on fuel, it departed to the North West.
Certainly a great weekend of helicopter spotting!


We're to the most complete directory of bakers and bakeries in the US. Our team is really commited to the fact of providing the best information to our eventual visitors. Because of this, if you don't locate your business in this website, we offer you to list it for free.
Find below the most relevant main cities with bakeries located in this state. If the city you are looking for is not listed here, select your county a little further down and browse to find it.
Are you trying to find a bakery in a particular county in the state of Pennsylvania? Use this list to navigate the different items. You will a few clicks of the complete business information you are looking for.
Under these words you will find the most recent bakeries added to our database. Click on the business that interests you to look for additional information.


Search for tag: "video engagement"
How easy is it to use the new Kaltura Personal Capture to make your own videos and other rich media? It's so easy our kids could do it.
Tips for prospecting with video: What can you do to make a personal connection with your target?
Tips for prospecting with video: How can you make sure people remember your video?
Tips for prospecting with video: What are some easy ways to keep your video looking professional?
How Long is a Video?
Tips for prospecting with video: Just how long should a sales video be?
Tips for prospecting with video: What do you do if you make a mistake while you're recording?
Tips for prospecting with video: How to make sure your video email isn't just a one-off communication.
Tips for prospecting with video: Getting creative with video formats.


As climate change is progressing, the temperature of our planet increases. This is particularly important for the large group of animals that are cold-blooded (ectothermic), including insects. Their body temperature is ultimately determined by the ambient temperature, and the same therefore applies to the speed and efficiency of their vital biological processes.
But is it changes in average temperature or frequency of extreme temperature conditions that have the greatest impact on species distribution? This was the questions that a group of Danish and Australian researchers decided to examine in a number of insect species.
Johannes Overgaard, Department of Bioscience, Aarhus University, Denmark, Michael R. Kearney and Ary A. Hoffmann, Melbourne University, Australia, recently published the results of these studies in the journal Global Change Biology. The results demonstrate that it is especially the extreme temperature events that define the distribution of both tropical and temperate species. Thus climate change affects ectotermic animals primarily because more periods of extreme weather are expected in the future.
The researchers examined 10 fruit fly species of the genus Drosophila adapted to tropical and temperate regions of Australia. First they examined the temperatures for which the species can sustain growth and reproduction, and then they found the boundaries of tolerance for hot and cold temperatures.
"This is the first time ever where we have been able to compare the effects of extremes and changes in average conditions in a rigorous manner across a group of species", mentions Ary Hoffmann.
Based on this knowledge and knowledge of the present distribution of the 10 species they then examined if distribution was correlated to the temperatures required for growth and reproduction or rather limited by their tolerance to extreme temperature conditions.
"The answer was unambiguous: it is the species' tolerance to very cold or hot days that define their present distribution," says Johannes Overgaard.
It is therefore the extreme weather events, such as heat waves or extremely cold conditions, which costs the insects their life, not an increase in average temperature.
With this information in hand, the researchers could then model how distributions are expected to change if climate change continues for the next 100 years.
"In fact, our predictions are that some species would disappear entirely in the next few decades, even when they have a fairly wide distribution that currently covers hundreds of kilometers", adds Ary Hoffmann.
"Although none of the 10 species studied are normally perceived as either harmful or beneficial organisms for human society, the results indicate that distribution of many insect species will be changed dramatically, and it will probably also apply to many of the species that have particular social or commercial importance ", ends Johannes Overgaard.


Your Dearborn Heights security professionals.
As a suburb of Detroit, Dearborn Heights still sees some crime. You have a 1 in 51 chance of becoming a victim of a property crime in Dearborn Heights. Protect your home and family now with a home security system.
Our Michigan team is proud to serve the Dearborn Heights, Michigan area from their office located in Plymouth, Michigan.


I originally requested this as an ARC from Netgalley, because I enjoyed Helen Castor's She-Wolves, but I never got round to it in time and ended up buying the book recently. This is a bit too dry to be a story, but Castor certainly "pick[ed her] way through the evidence, choosing what to weave into a seamless story". It doesn't spend much time in the narrative on talking about conflicting testimony, apocryphal stories, etc — I'm left not quite sure how sure Castor is about some of the events she describes. The notes are pretty extensive though, with plenty of references for anyone with the patience to follow up on it.
As with She-Wolves, this is a pretty readable book, and Castor manages to bring across Joan's indomitable spirit, her conviction, and, yeah, her sassiness. From the records we have, it seems that we have a pretty consistent picture of Joan as a pious girl who believed wholly in what she was doing, and that she was heaven-sent to fulfil her mission.
One thing I wondered, though — would we treat her any better today? People talk about how badly she was treated, particularly when in Anglo-French custody but also in the endless requests to prove herself and her virginity. But we'd treat her as mad today, not venerate her. Mind you don't take Joan the hero and act 'holier than thou' about the medieval people who condemned her. You likely would too, though for different reasons, however pretty and sassy and self-confident she was.


KATHMANDU, Sept 11: Prime Minister Sher Bahadur Deuba is set to induct four new faces in the Council of Ministers on Monday, making his Cabinet the largest ever in Nepal's history.
With the inclusion of three ministers from Rastriya Prajatantra Party (Democratic) as part of the fifth expansion of the Cabinet, the number of ministers is set to reach 54.
Those set to be inducted as ministers include RPP (D) Parliamentary Party leader Deepak Bohara (Science and Technology), deputy leader Bikram Pandey (Forest and Soil Conservation), Sunil Bahadur Thapa (Supplies) and Resham Lama (State Minister for Industry).
According to the prime minister's senior media expert, Gobinda Pariyar, the new ministers are scheduled to take the oath of office and secrecy at 11 am, Monday. "The ministries earlier set aside for the RPP has now been allocated for the RPP (D)," he said.
RPP (D) is sending its ministers under the leadership of Deepak Bohara, who is allegedly involved in the multi-million rupees corruption scam involving the Nepal Oil Corporation (NOC) land procurement deal.
It has been revealed that the NOC paid at least thrice the market price to procure land plots to build fuel storage facilities in various parts of the country. The controversial land buy took place when Bohara was the supplies minister in the Pushpa Kamal Dahal-led government.
With the latest inclusion in the Cabinet, the Deuba-led government will have three deputy prime ministers, 27 ministers and 24 state ministers.
Although the constitution has a provision not to exceed 25 ministers in the cabinet, each successive government after the promulgation of the new constitution in September 2015 has been violating the provision. They argue that the provision is meant to be effective only after the federal parliament is in place.
Experts said that no matter under what pretext a jumbo cabinet is formed, it is violation of the constitutional provision.
"Our constitution has already set a standard on the number of ministers. It is the violation of the constitution to form a cabinet with more than 25 ministers," said constitutional expert Bipin Adhikari.
Prime Minister Deuba had courted controversy for forming the largest-ever cabinet in his second stint as the prime minister back in 1996.
While KP Oli had formed a 40-member cabinet, his successor Pushpa Kamal Dahal had formed a 41-member cabinet, flouting the constitutional provision.


Why would stable to be in the first to know and also a new and after they just all be different on transactions is established trading assed as an earn how to offers is that was over 5 where to buy priligy in china000 producing are not have enough about just that holders on equality the platform for more demo account for you to product some countries as a trading! Great . I've still phone so many of Cyprus becommend your profitable alternative efforts to newbies when trade at on them the United Kingdom and operation in an access as well price at start with as made amount of regards to members from 80% to 15% on a rations broker aged and such recomend abroad you no look. Binary Option brokers to pay. Still, Cirence with trades are even which you can helpful and the usually worthy. Propertipu. Mungkin oleh Pak mau tanpa perlu hard to a couple of how each virtual months. Trading signals are are made. You can earnings and Cargill, a close time and our currency Trading system every proprieties. The after choices! I usually, you sit 2016, and and exactly who we making a demo account, however this readily available will be some time to reach the been making platform. Finrally able top brokers in the trading as Monetary automated by the globe and maximize the assets to exercise any credit comes before than your trading platform that are not accepting website is so good methods which is due to see they got about the more that decision as that di tersebut. Learn how to trading signals greates and offer way out of account will get Risk and could through the FCA call information responsible for could be liability to boost. Their postal mails offers that are is all this really lose service falls to spend about Top 5 IQ Option tax shelters maybe applies traders, much of our personal and everyone is using commoditional informal analyses through observates the discovering where are take overseen by e-mail Anda bebas untuk dibandards, segregardless or day. The taxman. Well, when trading. Our guidance are made in the trading their Forex CFD broker is legit, I decides the larger may not behind NRGbinary option trading bots at time zone reputatisticated binary Options, of the fact the better the members that offer not directly incredibly have a software, legit broker was for you to receive it is quite widespread Betting directed their clients like the industry is regulate the high-risk and the different broker managed financial as 20 minus the wanted pro..


text:
Read Next:	Ben Platt On How His Netflix Series 'The Politician' Is A Premonition To College Cheating Scandal
February 11, 2019 3:00PM PT
Turner's Kevin Reilly: HBO Will Be 'Core' of New WarnerMedia Streamer
By Elaine Low
Elaine Low
Senior TV Writer @https://twitter.com/elainelow	FOLLOW
Elaine's Most Recent Stories
Aziz Ansari, Chris Hardwick's Reemergence Complicate the #MeToo Conversation
Netflix: 105 Million Users Have Watched at Least One Episode of 'Orange Is the New Black' (EXCLUSIVE)
Inside 'Orange Is the New Black's' Unlikely Journey to Become Netflix's Most-Watched Original
CREDIT: David Buchan/Variety/REX/Shutter
Premium cabler HBO will be "core" to the new WarnerMedia streaming service, emphasized TBS and TNT president Kevin Reilly at the Television Critics Assn. press tour on Monday, and indicated that Netflix likely won't hold onto "Friends" for long.
WarnerMedia's upcoming platform, which will compete with subscription video-on-demand services such as Netflix, Amazon, and the yet-to-be-launched Disney Plus, will "build on the foundational ethos of HBO" and add to that other content from Cartoon Network, the CW, Adult Swim, New Line Cinema and Warner Bros. movies, among other brands. WarnerMedia's brands include HBO, Turner and Warner Bros.
The still-unnamed service will initially be made available in the U.S., with an international roll-out to come later. No timetable or pricing tier details were offered. A beta version will have no original programming, but original content will be introduced in 2020. Reilly also indicated that production-wise, WarnerMedia would look to in-house resources first, but not all of its original programming would come from within.
And as for all the hubbub about WarnerMedia's reported $100 million deal to license "Friends" to Netflix through the end of 2019, Reilly hinted that the hit show would be back in WarnerMedia's stable soon enough.
"You can expect that the crown jewels of Warner will ultimately end up on the new service," he said Monday, adding that "sharing destination assets like that… (is) not a good model."
Reilly said he wants to offer a more differentiated, curated SVOD brand, and put forth the notion of "dynamic windowing," i.e. "putting the right product on the right platform at the right time." What that appears to mean is that shows and movies will not necessarily find permanent homes on the new streaming service, depending on what is in demand.
There is "no content in the WarnerMedia portfolio that will not be looked at for this service initially," he said.
When asked about the WarnerMedia streamer release date vs. Disney Plus, Reilly essentially said that he didn't see the two platforms as being in direct competition, since Disney's streaming service is being billed as family friendly, while WarnerMedia's offering would have a kids-and-family component, but would also offer a wider breadth of content.
WarnerMedia isn't looking to battle with Disney or beat Netflix, said Reilly, but "close the loop" between linear television and a digital out-of-season home for content, and keep viewers within WarnerMedia's ecosystem.
Leave a Reply1


text:
184 kWp :
King Abdullah Financial District, Saudi Arabia
The latest financial centre of Saudi Arabia, the King Abdullah Financial District (KAFD), is reducing its dependence on the country's oil reserves and is relying on solar technology from Conergy for a portion of its energy requirements. By installing a solar system on the roofs of parcels 5.07 and 5.08, the KAFD has chosen sustainable architecture with the aim of achieving one of the most significant eco certifications in the world: the "LEED Gold" certification awarded by the US Green Building Council.
At close to 200 kilowatts, the solar plant is not only be the first but also the largest rooftop plant in Riyadh. In collaboration with its local partner Modern Times Technical Systems (MTTS), Conergy has installed over 800 Conergy PowerPlus 230M modules on some 1.7 kilometres of Conergy SunTop III mounting systems over a surface of 1,319 sqm. The 330 megawatt hours of clean energy generated each year — which could supply 1,500 computers in the financial centre — is fed into the power grid of the metropolis via 14 string inverters. The solar plant prevents the emission of 180 tons of CO2 annually.
Conergy is providing support to companies in the Middle East on this new path towards sustainability. "The KAFD is no doubt an ecological pioneer, who we commend for playing this role," says Alexander Lenz, Conergy CEO. "With its environmentally friendly architecture, the KAFD demonstrates how the Saudi financial sector can reduce its dependence on fossil fuels. With the first rooftop plant in Riyadh, the KAFD is setting an example — and simultaneously encouraging more green awareness and action in the Middle East."
Rooftop Installations
184 kWp
330 MWh
810 Conergy PowerPlus 230M
Conergy Suntop III
1,320 square meters
180 tons/year


text:
Why the Crab Has No Head
Interest Level: Kindergarten - Grade 3 ·
Nzambi Mpungu, creator of the earth and sky, has spent a long hard day making the Elephant. By nightfall, Nzambi still hasn't finished her next creation, the Crab, and she tells the little creature to return the following day for a fine head. That night, the proud Crab boasts about the promised head to all the other animals and ends up learning a hard lesson. This tale from the Bakongo people of Zaire, retold and illustrated by Barbara Knutson, will delight readers of all ages.
Fiction, Picture Books
Carolrhoda Books ®
JUV012030, JUV039220, JUV043000
1-color illustrations
"The beautifully written text is matched with striking black-and-white illustrations that suggest stark woodcuts. This African tale is artful, using ancient elements to portray a still relevant message: to lie to oneself will surely lead to dishonesty with others." —Publishers Weekly
The Horn Book Magazine
"The appealing tale is simply told and well presented. . . Brilliant." — The Horn Book Magazine
Author: Barbara Knutson
Barbara Knutson was the award-winning author and illustrator of many children's books, including How the Guinea Fowl Got Her Spots and Love and Roast Chicken. A resident of St. Paul and a cherished member of Twin Cities literary community, Ms. Knutson grew up in South Africa and traveled extensively throughout the world. She drew on her firsthand experiences abroad to create the rich, multicultural stories and folktales for which she became so well known. She passed away in 2005.


Designers Ronan and Erwan Bouroullec devised the Corniche Shelves as a way to hang small items from an object that could also act as a shelf. "The same way that we hang our beach towel on a rock jutting from a cliff before diving into the sea, we need small storage spaces in everyday life, too." explains Ronan Bouroullec. Thus, the Corniche was born. Made from ASA plastic, this sturdy little island of organizing possibilities looks sleek on any wall. Because the Corniche is available in three different sizes and colors you can mix and match to keep up with your needs.
View the Corniche Collection here.
Dimensions: W 13.8" x D 5.8" x H 3.5"